USAA
LCTX icon

United Services Automobile Association’s Lineage Cell Therapeutics LCTX Stock Holding History

United Services Automobile Association’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,411
Closed -$28K – 1145
2019
Q2 		$28K Hold
25,411
– – ﹤0.01% 2201
2019
Q1 		$33K Hold
25,411
– – ﹤0.01% 2223
2018
Q4 		$23K Sell
25,411
-3,634
-13% -$5.57K ﹤0.01% 2206
2018
Q3 		$60K Hold
29,045
– – ﹤0.01% 2257
2018
Q2 		$52K Hold
29,045
– – ﹤0.01% 2256
2018
Q1 		$68K Buy
+29,045
New +$68.1K ﹤0.01% 2205

Other funds holding LCTX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $319M AUM 12.55% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

United Services Automobile Association's LCTX Position: Q3 2019 in Review

United Services Automobile Association sold out of Lineage Cell Therapeutics (LCTX) in Q3 2019, closing a stake of 25,411 shares — an estimated $28K sold.

United Services Automobile Association first reported a position in LCTX in Q1 2018 and held it in 6 quarters. The position peaked at $68K in Q1 2018. 96 funds tracked by Wall St. Rank hold LCTX as of Q3 2019.

  • United Services Automobile Association reported no remaining Lineage Cell Therapeutics position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 25,411 Lineage Cell Therapeutics shares in Q3 2019, an estimated $28K.
  • United Services Automobile Association first reported a position in Lineage Cell Therapeutics in Q1 2018 and held it in 6 quarters.
  • United Services Automobile Association's Lineage Cell Therapeutics position peaked at $68K in Q1 2018.
  • 96 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.